Alphabet-backed point-of-sale technology developer Toast has added $101m to its coffers to fund further development of its cloud platform.

Pfizer Venture Investments led the small-molecule cancer drug developer's $38.6m series C round, which included Novartis, GlaxoSmithkline, AbbVie and Astellas.

The personalised marketing technology producer has increased its series C to $31m, with Deutsche Telekom joining a round that already included Baidu.

Lundbeck's corporate venturing unit contributed to a series C round led by New Enterprise Associates which will advance Trevi Therapeutics' lead pruritus treatment.

Used vehicle e-commerce platform Shift has now raised more than $110m altogether and added BMW i Ventures to its investor base.

GE Ventures has led a $14.1m series C round for online health insurance marketplace Gravie, a year after the company received $1m from insurer Securian.

Brain Corp has raised $114m in a series C round led by SoftBank Vision Fund that included existing investor and strategic partner Qualcomm.

Novo participated in Menlo's series C round, which follows the completion of two clinical trials for the skin condition drug developer's lead product candidate.

ANA Holdings and OSG Corporation will supply technical assistance to the space debris reduction technology developer, after taking part in its series C round.

Salesforce Ventures has reinvested in customer engagement platform Pendo as part of a series C round, seven months after backing its $20m series B.